{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:29:28Z","timestamp":1747668568357},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Breastfeed J"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1186\/1746-4358-9-2","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T07:27:36Z","timestamp":1389857256000},"source":"Crossref","is-referenced-by-count":18,"title":["Regulating fatty acids in infant formula: critical assessment of U.S. policies and practices"],"prefix":"10.1186","volume":"9","author":[{"given":"George","family":"Kent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"193_CR1","volume-title":"New York Times","author":"JE Brody","year":"1996","unstructured":"Brody JE: Experts disagree on adding fatty acid to infant formula. New York Times 1996. [\n                    http:\/\/www.nytimes.com\/1996\/11\/06\/us\/experts-disagree-on-adding-fatty-acid-to-infant-formula.html?pagewanted=all&src=pm\n                    \n                  ]"},{"key":"193_CR2","volume-title":"EAS Strateg Advice: Europe","author":"C Guidice","year":"2012","unstructured":"Guidice C: Harmonisation: Mercosur gets to work on nutrition claims. EAS Strateg Advice: Europe 2012. [\n                    http:\/\/www.eas.eu\/News_Item\/921\n                    \n                  ]"},{"key":"193_CR3","volume-title":"Nutra Ingredients.com","author":"M Astley","year":"2012","unstructured":"Astley M: ISO to cooperate with AOAC on infant formula standards. Nutra Ingredients.com; 2012. [\n                    http:\/\/www.nutraingredients.com\/Regulation\/ISO-to-cooperate-with-AOAC-on-infant-formula-standards\n                    \n                  ]"},{"key":"193_CR4","volume-title":"Global Organization for EPA and DHA Omega-3","author":"GOED","year":"2012","unstructured":"GOED: Global Organization for EPA and DHA Omega-3. 2012. Website [\n                    http:\/\/www.goedomega3.com\n                    \n                  ]"},{"key":"193_CR5","unstructured":"Codex Alimentarius Commission: Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants. CODEX STAN 72\u20131981. (Formerly CAC\/RS 72\u20131972. Adopted as a world-wide Standard 1981. Amended 1983, 1985, 1987. Revision 2007. Amended 2011). [\n                    http:\/\/www.codexalimentarius.org\n                    \n                  ]"},{"key":"193_CR6","volume-title":"Title 21 Part 107 (21CFR107)","author":"U.S. Code of Federal Regulations","year":"2003","unstructured":"U.S. Code of Federal Regulations: Title 21 Part 107 (21CFR107). 2003. [\n                    http:\/\/www.access.gpo.gov\/nara\/cfr\/waisidx_03\/21cfr107_03.html\n                    \n                  ]"},{"issue":"11","key":"193_CR7","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1017\/S0007114508084080","volume":"101","author":"RA Gibson","year":"2009","unstructured":"Gibson RA, Barclay D, Marshall H, Moulin J, Maire J-C, Makrides M: Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomized controlled trial. Br J Nutr. 2009, 101 (11): 1706-1713. 10.1017\/S0007114508084080.","journal-title":"Br J Nutr"},{"key":"193_CR8","volume-title":"Regulating infant formula","author":"G Kent","year":"2011","unstructured":"Kent G: Regulating infant formula. Amarillo, Texas: Hale Publishing; 2011."},{"key":"193_CR9","volume-title":"Beech-Nut Corporation 2\/22\/10. Warning Letter","author":"U.S. Department of Health and Human Services","year":"2010","unstructured":"U.S. Department of Health and Human Services: Beech-Nut Corporation 2\/22\/10. Warning Letter. Washington, DC: USDHHS: Food and Drug Administration; 2010. [\n                    http:\/\/www.fda.gov\/iceci\/enforcementactions\/warningletters\/ucm202834.htm\n                    \n                  ]"},{"key":"193_CR10","volume-title":"Replacing mother\u2013imitating human breast milk in the laboratory","author":"C Vallaeys","year":"2008","unstructured":"Vallaeys C: Replacing mother\u2013imitating human breast milk in the laboratory. Cornucopia, Wisconsin: Cornucopia Institute; 2008. [\n                    http:\/\/www.cornucopia.org\/2008\/01\/replacing-mother-infant-formula-report\/\n                    \n                  ]"},{"key":"193_CR11","volume-title":"Living Wholesome","author":"Living Wholesome","year":"2011","unstructured":"Living Wholesome: Horizon organic gets flogged for bending its definition of \u2018organic\u2019. Living Wholesome 2011."},{"key":"193_CR12","volume-title":"Food Safety News","author":"C Mitchell","year":"2011","unstructured":"Mitchell C: Challenge to horizon organic\u2019s DHA fortified milk. Food Safety News 2011. [\n                    http:\/\/www.foodsafetynews.com\/2011\/03\/challenge-to-horizon-organics-new-dha-fortified-milk\/\n                    \n                  ]"},{"key":"193_CR13","volume-title":"Letter to Deputy Administrator of National Organic Program, USDA","author":"U.S. Department of Health and Human Services","year":"2011","unstructured":"U.S. Department of Health and Human Services: Letter to Deputy Administrator of National Organic Program, USDA. Washington, DC: USDHHS: Food and Drug Administration; 2011."},{"key":"193_CR14","volume-title":"Baltimore Sun","author":"TJ Mullaney","year":"1994","unstructured":"Mullaney TJ: Martek sells its first product. Baltimore Sun 1994. [\n                    http:\/\/articles.baltimoresun.com\/1994-12-14\/business\/1994348144_1_martek-biotechnology-baby-formulas\n                    \n                  ]"},{"key":"193_CR15","volume-title":"Life\u2019s DHA: Healthy Brain, Eyes, Heart","author":"Martek","year":"2012","unstructured":"Martek: Infant benefits: DHA & ARA for infants health. Life\u2019s DHA: Healthy Brain, Eyes, Heart 2012. [\n                    http:\/\/www.lifesdha.com\/dha-at-every-age\/infants.aspx\n                    \n                  ]"},{"key":"193_CR16","doi-asserted-by":"crossref","unstructured":"Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH: Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics. 2012, 129 (6).","DOI":"10.1542\/peds.2011-2127"},{"key":"193_CR17","volume-title":"Cochrane Database Syst Rev","author":"K Simmer","year":"2008","unstructured":"Simmer K, Schulzke S, Patole S: Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008."},{"key":"193_CR18","volume-title":"Cochrane Database Syst Rev","author":"K Simmer","year":"2008","unstructured":"Simmer K, Patole S, Rao SC: Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008."},{"key":"193_CR19","volume-title":"Infant development: the benefits of DHA and ARA during infancy","author":"Martek","year":"2012","unstructured":"Martek: Infant development: the benefits of DHA and ARA during infancy. 2012. [\n                    http:\/\/www.lifesdha.com\/clinical-research\/infant-development.aspx\n                    \n                  ]"},{"key":"193_CR20","volume-title":"Martek to be the sole-source supplier of DHA and ARA for prodigy brand infant formula products in China","author":"Martek","year":"2009","unstructured":"Martek: Martek to be the sole-source supplier of DHA and ARA for prodigy brand infant formula products in China. Columbia, Maryland: Martek Biosciences Corporation; 2009. [\n                    http:\/\/www.bloomberg.com\/apps\/news?pid=newsarchive&sid=aazU8t4zmy_M\n                    \n                  ]"},{"key":"193_CR21","volume-title":"Martek to be the sole source supplier of DHA and ARA for infant formulas produced by Grupo Ricap","author":"Martek","year":"2009","unstructured":"Martek: Martek to be the sole source supplier of DHA and ARA for infant formulas produced by Grupo Ricap. Columbia, Maryland: Martek Biosciences Corporation; 2009. [\n                    http:\/\/www.bloomberg.com\/apps\/news?pid=newsarchive&sid=a1SoDaBD_5t8\n                    \n                  ]"},{"key":"193_CR22","volume-title":"Martek signs sole-source supply agreement with Fonterra","author":"Martek","year":"2009","unstructured":"Martek: Martek signs sole-source supply agreement with Fonterra. Columbia, Maryland: Martek Biosciences Corporation; 2009. [\n                    http:\/\/www.prweb.com\/releases\/dairy_fonterra\/martek_biosciences\/prweb3321614.htm\n                    \n                  ]"},{"key":"193_CR23","volume-title":"About life\u2019s DHA","author":"Martek","year":"2012","unstructured":"Martek: About life\u2019s DHA. 2012. [\n                    http:\/\/www.lifesdha.com\/dha-at-every-age\/infants.aspx\n                    \n                  ]"},{"issue":"6","key":"193_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1542\/peds.2012-0934","volume":"129","author":"J Colombo","year":"2012","unstructured":"Colombo J, Carlson SE: Is the measure the message: the BSID and nutritional interventions. Pediatrics. 2012, 129 (6): 1166-1167. 10.1542\/peds.2012-0934.","journal-title":"Pediatrics"},{"key":"193_CR25","volume-title":"Questions & answers for consumers concerning infant formula","author":"U.S. Department of Health and Human Services","year":"2013","unstructured":"U.S. Department of Health and Human Services: Questions & answers for consumers concerning infant formula. Washington, DC: USDHHS Food and Drug Administration; 2013.[\n                    http:\/\/www.fda.gov\/Food\/FoodborneIllnessContaminants\/PeopleAtRisk\/ucm108079.htm#16\n                    \n                  ]"},{"issue":"1","key":"193_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1891\/215805312807010809","volume":"3","author":"G Kent","year":"2012","unstructured":"Kent G: The nutritional adequacy of infant formula. Clin Lactation. 2012, 3 (1): 21-25.","journal-title":"Clin Lactation"},{"key":"193_CR27","volume-title":"Baby\u2019s Only Essentials\u00ae DHA Fatty Acid Supplement","author":"Nature\u2019s One","year":"2012","unstructured":"Nature\u2019s One: Baby\u2019s Only Essentials\u00ae DHA Fatty Acid Supplement. 2012. [\n                    http:\/\/www.naturesone.com\/dha\/#\n                    \n                  ]"},{"key":"193_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tox.2005.10.023","volume":"221","author":"JC Rowlands","year":"2006","unstructured":"Rowlands JC, Hoadley J: FDA perspective on health claims for food labels. Toxicology. 2006, 221: 35-43. 10.1016\/j.tox.2005.10.023.","journal-title":"Toxicology"},{"issue":"2","key":"193_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jn\/137.2.493","volume":"137","author":"B Schneeman","year":"2007","unstructured":"Schneeman B: FDA\u2019s review of scientific evidence for health claims. J Nutr. 2007, 137 (2): 493-494.","journal-title":"J Nutr"},{"issue":"3","key":"193_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/17482970701685625","volume":"51","author":"AL Reutersw\u00e4rd","year":"2007","unstructured":"Reutersw\u00e4rd AL: The new EC regulation on nutrition and health claims on foods. Scand J Food Nutr. 2007, 51 (3): 100-106. 10.1080\/17482970701685625.","journal-title":"Scand J Food Nutr"},{"key":"193_CR31","volume-title":"Is it really FDA approved?","author":"U.S. Department of Health and Human Services","year":"2012","unstructured":"U.S. Department of Health and Human Services: Is it really FDA approved? USDHHS. Food and Drug Administration; 2012. [\n                    http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm047470.htm#formula\n                    \n                  ]"},{"key":"193_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1542\/peds.2012-0333","volume":"130","author":"CS Chung","year":"2012","unstructured":"Chung CS, Yamini S, Trumbo PR: FDA\u2019s health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis. Pediatrics. 2012, 130: 2.","journal-title":"Pediatrics"},{"key":"193_CR33","volume-title":"Health claims meeting Significant Scientific Agreement (SSA)","author":"U.S. Department of Health and Human Services","year":"2012","unstructured":"U.S. Department of Health and Human Services: Health claims meeting Significant Scientific Agreement (SSA). USDHHS. Food and Drug Administration; 2012. [\n                    http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm2006876.htm\n                    \n                  ]"},{"key":"193_CR34","volume-title":"Infant Feeding & Nutrition","author":"Infant Formula Council","year":"2010","unstructured":"Infant Formula Council: Infant Formula Council (IFC) statement on DHA\/ARA and infant formula. Infant Feeding & Nutrition 2010. [\n                    http:\/\/www.infantformula.org\/news-room\/press-releases-and-statements\/infant-formula-and-dha\/ara\n                    \n                  ]"},{"key":"193_CR35","volume-title":"Guidelines concerning notification and testing of infant formulas","author":"U.S. Department of Health and Human Services","year":"2009","unstructured":"U.S. Department of Health and Human Services: Guidelines concerning notification and testing of infant formulas. Washington, DC: USDHHS, Food and Drug Administration, Center for Food Safety and Applied Nutrition; 2009. [\n                    http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/InfantFormula\/ucm169730.htm\n                    \n                  ]"},{"key":"193_CR36","volume-title":"Agency Response Letter, GRAS Notice No. GRN 000041","author":"U.S. Department of Health and Human Services","year":"2001","unstructured":"U.S. Department of Health and Human Services: Agency Response Letter, GRAS Notice No. GRN 000041. Washington, DC: USDHHS, Food and Drug Administration; 2001. [\n                    http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/NoticeInventory\/ucm154126.htm\n                    \n                  ]"},{"key":"193_CR37","volume-title":"GRAS notice inventory","author":"U.S. Department of Health and Human Services","year":"2012","unstructured":"U.S. Department of Health and Human Services: GRAS notice inventory. USDHHS. Food and Drug Administration; 2012.[\n                    http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/NoticeInventory\/default.htm\n                    \n                  ]"},{"key":"193_CR38","volume-title":"Guidance for industry: frequently asked questions about GRAS","author":"U.S. Department of Health and Human Services","year":"2004","unstructured":"U.S. Department of Health and Human Services: Guidance for industry: frequently asked questions about GRAS. USDHHS. Food and Drug Administration; 2004. [\n                    http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/IngredientsAdditivesGRASPackaging\/ucm061846.htm\n                    \n                  ]"},{"key":"193_CR39","volume-title":"Agency Response Letter, GRAS Notice No. GRN 000080","author":"U.S. Department of Health and Human Services","year":"2001","unstructured":"U.S. Department of Health and Human Services: Agency Response Letter, GRAS Notice No. GRN 000080. Washington, DC: USDHHS. Food and Drug Administration; 2001. [\n                    http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/NoticeInventory\/ucm154201.htm\n                    \n                  ]"},{"key":"193_CR40","volume-title":"DHA and ARA in infant formula: dangerous and unnecessary\u2014synthetic additives have no place in infant foods","author":"C Vallaeys","year":"2012","unstructured":"Vallaeys C: DHA and ARA in infant formula: dangerous and unnecessary\u2014synthetic additives have no place in infant foods. Cornucopia, Wisconsin: Cornucopia Institute; 2012. [\n                    http:\/\/cornucopia.org\/DHA\/DHA-Update-2010.pdf\n                    \n                  ]"},{"key":"193_CR41","volume-title":"Safety concerns: inadequate safety testing of Martek\u2019s DHA and ARA","author":"Cornucopia","year":"2012","unstructured":"Cornucopia: Safety concerns: inadequate safety testing of Martek\u2019s DHA and ARA. Cornucopia, Wisconsin: Cornucopia Institute; 2012. [\n                    http:\/\/www.cornucopia.org\/dha-safety-concerns\/\n                    \n                  ]"},{"key":"193_CR42","volume-title":"Official adverse reaction reports filed with the Food and Drug Administration","author":"Cornucopia","year":"2012","unstructured":"Cornucopia: Official adverse reaction reports filed with the Food and Drug Administration. Cornucopia, Wisconsin: Cornucopia Institute; 2012. [\n                    http:\/\/cornucopia.org\/DHA\/AdverseReactionReports.pdf\n                    \n                  ]"},{"key":"193_CR43","volume-title":"INFACT Canada: Spring 1997 Newsletter: Breastfeeding Protection: Code Watch","author":"INFACT Canada","year":"1997","unstructured":"INFACT Canada: Fools gold: recommendation: strong buy. INFACT Canada: Spring 1997 Newsletter: Breastfeeding Protection: Code Watch. 1997. [\n                    http:\/\/www.infactcanada.ca\/codewach.htm\n                    \n                  ]"},{"key":"193_CR44","volume-title":"WIC food package should be based on science: foods with new functional ingredients should be provided only if they deliver health or nutritional benefits","author":"Z Neuberger","year":"2010","unstructured":"Neuberger Z: WIC food package should be based on science: foods with new functional ingredients should be provided only if they deliver health or nutritional benefits. Washington, DC: Center on Budget and Policy Priorities; 2010. [\n                    http:\/\/www.cbpp.org\/files\/6-4-10fa.pdf\n                    \n                  ]"},{"key":"193_CR45","volume-title":"Podcast: new ingredients raising costs for \u201cWIC\u201d program","author":"Z Neuberger","year":"2010","unstructured":"Neuberger Z: Podcast: new ingredients raising costs for \u201cWIC\u201d program. Washington, DC: Center on Budget and Policy Priorities; 2010. [\n                    http:\/\/www.cbpp.org\/cms\/index.cfm?fa=view&id=3213\n                    \n                  ]"},{"key":"193_CR46","volume-title":"Alma Publications","author":"MK Minchin","year":"2014","unstructured":"Minchin MK: Milk Matters: Immune Disorder and Infant Feeding. Alma Publications, in press 2014."},{"key":"193_CR47","volume-title":"FTC warns marketers of children\u2019s omega-3 fatty acid supplements that claims about brain and vision benefits may be deceptive","author":"U.S. Federal Trade Commission","year":"2010","unstructured":"U.S. Federal Trade Commission: FTC warns marketers of children\u2019s omega-3 fatty acid supplements that claims about brain and vision benefits may be deceptive. Washington, DC: USFTC; 2010. [\n                    http:\/\/www.ftc.gov\/opa\/2010\/02\/omega.shtm\n                    \n                  ]"},{"key":"193_CR48","volume-title":"FTC approves final order settling charges that marketer of children\u2019s vitamins made deceptive claims about DHA and brain and eye development","author":"U.S. Federal Trade Commission","year":"2011","unstructured":"U.S. Federal Trade Commission: FTC approves final order settling charges that marketer of children\u2019s vitamins made deceptive claims about DHA and brain and eye development. Washington, DC: USFTC; 2011. [\n                    http:\/\/www.ftc.gov\/opa\/2011\/03\/nbty.shtm\n                    \n                  ]"},{"key":"193_CR49","volume-title":"Draft guidance for industry: frequently asked questions about medical foods","author":"U.S. Department of Health and Human Services","year":"2011","unstructured":"U.S. Department of Health and Human Services: Draft guidance for industry: frequently asked questions about medical foods. USDHHS. Food and Drug Administration; 2011. [\n                    http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/MedicalFoods\/ucm054048.htm#q1\n                    \n                  ]"},{"issue":"3\u20134","key":"193_CR50","first-page":"E46","volume":"181","author":"R Collier","year":"2011","unstructured":"Collier R: Squabble over risks of probiotics infant formula. Can Med Assoc J. 2011, 181 (3\u20134): E46-E47.","journal-title":"Can Med Assoc J"},{"key":"193_CR51","doi-asserted-by":"crossref","unstructured":"Mugambi M, Musekiwa A, Lombard M, Young T, Blaauw R: Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review. Nutr J. 2012, 11 (58).","DOI":"10.1186\/1475-2891-11-58"},{"key":"193_CR52","volume-title":"Probiotic.org","author":"Probiotic","year":"2011","unstructured":"Probiotic: Safety of probiotic products. Probiotic.org 2011. [\n                    http:\/\/www.probiotic.org\/safety-of-probiotics.htm\n                    \n                  ]"},{"key":"193_CR53","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1542\/peds.2008-3557","volume":"123","author":"T Shafai","year":"2009","unstructured":"Shafai T: Routine supplement of prebiotics and probiotics to newborn infants are not recommended [Letter]. Pediatrics. 2009, 123: e543-e544. 10.1542\/peds.2008-3557.","journal-title":"Pediatrics"},{"issue":"6","key":"193_CR54","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1440-1754.2002.00056.x","volume":"38","author":"VY Yu","year":"2002","unstructured":"Yu VY: Scientific rationale and benefits of nucleotide supplementation of infant formula. J Paediatr Child Health. 2002, 38 (6): 543-549. 10.1046\/j.1440-1754.2002.00056.x.","journal-title":"J Paediatr Child Health"},{"key":"193_CR55","volume-title":"Target 5","author":"L Parker","year":"2012","unstructured":"Parker L, Green R: Why doesn\u2019t baby formula list sugar content? Target 5 2012. [\n                    http:\/\/www.nbcchicago.com\/investigations\/series\/target-5\/target-5-sugar-baby-formula-139339308.html\n                    \n                  ]"},{"key":"193_CR56","volume-title":"UBIC Consulting","author":"UBIC","year":"2013","unstructured":"UBIC: Ingredients for the world infant formula market. UBIC Consulting 2013. [\n                    http:\/\/www.ubic-consulting.com\/template\/fs\/documents\/Nutraceuticals\/Ingredients-in-the-world-infant-formula-market.pdf\n                    \n                  ]"},{"key":"193_CR57","volume-title":"China baby food & drink market analysis and forecast to 2015","author":"Renub Research","year":"2012","unstructured":"Renub Research: China baby food & drink market analysis and forecast to 2015. 2012. [\n                    http:\/\/www.marketresearch.com\/Renub-Research-v3619\/China-Baby-Food-Drink-Forecast-7086732\/\n                    \n                  ]"},{"key":"193_CR58","volume-title":"Dairy Reporter.com","author":"G Montague-Jones","year":"2009","unstructured":"Montague-Jones G: Martek signs omega-3,-6 supply deal with Fonterra. Dairy Reporter.com 2009. [\n                    http:\/\/www.dairyreporter.com\/Financial\/Martek-signs-omega-3-6-supply-deal-with-Fonterra\n                    \n                  ]"}],"container-title":["International Breastfeeding Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-4358-9-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-4358-9-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-4358-9-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:15:18Z","timestamp":1548119718000},"score":1,"resource":{"primary":{"URL":"https:\/\/internationalbreastfeedingjournal.biomedcentral.com\/articles\/10.1186\/1746-4358-9-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1186\/1746-4358-9-2","relation":{},"ISSN":["1746-4358"],"issn-type":[{"value":"1746-4358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]},"article-number":"2"}}